subject: Infectious Diseases Vaccine Market Overview - Market Research Report On Aarkstore Enterprise [print this page] Introduction Introduction
Long being regarded as an unattractive market, vaccines have re-emerged as successful growth driver for Big Pharma. The launch and rapid uptake of novel, high-price products such as Wyeths Prevnar or Merck & Cos Gardasil, along with the emergence of novel vaccine technologies and favourable legislation have brought vaccines back into the main focus of pharmaceutical and biotech companies.
Features and benefits
Market overview with current market assessment in terms of leading players, brands and geographies
In-depth analyses of the leading 5 players portfolios, R&D pipelines, sales trends, geographic spread, licensing patterns and strategic outlook
Discussion of key developments shaping the sector: new technologies, indications and geographies
Snapshot profiles of second tier companies in the sector
Highlights
Driven by its increasing commercial potential, the vaccines sector has been subject to significant consolidation over the last 5 years. While some of this recent activity has paved the way for newer market entrants, at the same time, established players have sought to diversify their portfolios through new acquisitions.
Key opportunities for vaccine manufacturers lie in the exploitation of novel targets with a high unmet need. Development of candidates for these indications can be facilitated by novel technologies, such as adjuvants, alternative production and delivery techniques, and novel approaches in antigen design.
Faced with limited growth prospects in the western markets, companies are increasingly turning towards emerging countries. The higher disease burden, greater medical unmet needs combined with rapid economic growth, a growing affluent middle class and private sector in these countries represents significant potential for market expansion.
Your key questions answered
Get a comprehensive, insightful commercial overview of the vaccines market
Learn about the strategies of the Big 5 players, their strengths, weaknesses, similarities and differences
Gain insight into the future directions and growing strategic importance of vaccines for Big Pharma
Table of Contents :
OVERVIEW 1
Catalyst 1
Summary 1
About Datamonitor healthcare 2
About the Vaccines & Infectious Diseases Pharmaceutical Analysis Team 2
